Weekly News Recap #Phispers
Astra targets US$ 80 bn revenue by 2030, invests US$ 1.5 bn in ADC plant; Lilly’s weekly insulin scores late-stage wins
In this week’s news, AstraZeneca has laid out an ambitious plan to achieve US$ 80 billion in revenue by 2030. The drugmak...
Impressions : 1031
Pfizer’s Covid-19 pill retains 89 percent efficacy, works on Omicron; CSL buys Vifor for US$ 11.7 billion
In
this week’s Phispers, we bring you news on several M&As and tie-ups along with updates on Covid-19 medications an...
Impressions : 1660
Drugmakers test vaccine efficacy against Omicron; FDA panel recommends Merck’s antiviral despite safety concerns
In this week’s Phispers, we bring you updates on the new Covid-19 variant – Omicron – and how vaccine makers ...
Impressions : 1863
FDA safety review to hold up Moderna’s vaccine for teens; FDA raises concerns at Biocon’s Malaysia site
This
week, Phispers has more updates from Merck. The drugmaker has temporarily
withdrawn its pre-merger notification and repo...
Impressions : 1278
CDC finds Moderna to be most effective Covid jab; two Indian CROs under FDA lens over data integrity issues
This week, Phispers brings you updates on Covid vaccines,
news on regulatory actions, legal battles involving drugmakers and d...
Impressions : 1639
Another Lupin facility gets FDA’s OAI classification; layoffs at GSK’s R&D ops; Sandoz gets new CEO
This week Phispers has news on regulatory action, a new CEO appointment, lobbying, data theft and layoffs.
Another plant of I...
Impressions : 3809
BMS-Celgene mega-merger gets shareholder nod; 10 people die in another industrial accident in China
This week, Phispers brings you an update on the US$ 74 billion BMS-Celgene mega-merger, which was facing investor opposition.
...
Impressions : 1945
Another massive explosion in a chemical plant rocks China; Lilly discloses drug pricing data for insulin
This week, Phispers brings news that
J&J and Bayer have settled more than 25,000 lawsuits in the US against
their blood t...
Impressions : 1933
FDA raises cGMP concerns at Lupin’s US, India units; Sanofi begins hunt for new CEO
This week, Phispers brings you news about the CEOs of Sandoz and Sanofi.
While Richard Francis, CEO of Novartis’ generi...
Impressions : 4162
New Twists to Sartans Impurities Saga; Fish Oil Drug Makes Heart Medicine History
This week, Phispers brings you new twists to the valsartan impurities saga.
First, the FDA posted its observations at Zhejiang...
Impressions : 3644
FDA, EMA highlight more concerns over APIs from China; FDA slams Apotex’s India operations
This week, Phispers brings you more news on quality problems with active pharmaceutical ingredients from China. The FDA commiss...
Impressions : 4966
Global drug sales to hit US$ 1.2 trillion by 2024; Gates launches biotech startup
This week in Phispers, we bring you the world drug forecasts and trends from Evaluate Pharma. There is news from Novo Nordisk a...
Impressions : 3285
Japan approves drug that cures flu in as soon as 24 hours; Teva repositions brand, shuts offices in US
This week Phispers covers Xofluza, a drug approved in Japan that kills the influenza virus in 24 hours. It is poised to give Ro...
Impressions : 4461
Novartis considering a sale of Sandoz’s oral solids business; Sanofi’s dengue vaccine found to make disease worse
This week, Phispers brings you news on the biggest M&A deal of 2017 — the acquisition of health insurer Aetna by phar...
Impressions : 3832
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.